Inhibition of noradrenaline release by neuropeptide Y in mouse atria does not involve inhibition of adenylate cyclase or a pertussis toxin-susceptible G protein.

Naunyn-Schmiedeberg's Archives of Pharmacology
S Foucart, H Majewski

Abstract

Neuropeptide Y (30-1000 nmol/l) significantly inhibited the fractional stimulation-induced outflow of radioactivity from mouse atria preincubated with [3H]-noradrenaline. The inhibitory effect of neuropeptide Y was observed at all frequencies tested (2, 5 and 10 Hz) as well as after alpha-adrenoceptor blockade with phentolamine (1 mumol/l). A combination of 8-bromo adenosine cyclic-3'-5'-monophosphate (90 or 270 mumol/l) with the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (100 mumol/l) was used to saturate maximally the adenylate cyclase system and these drug combinations significantly enhanced the stimulation-induced outflow of radioactivity. However, neuropeptide Y inhibited the stimulation-induced outflow in the presence of these drugs, suggesting that the inhibitory effect of neuropeptide Y was not due to decreasing endogenous cyclic AMP formation. Finally, atria from mice treated with pertussis toxin were used. In this case, the inhibitory effect of neuropeptide Y on the stimulation-induced outflow of radioactivity was still observed suggesting that inhibitory prejunctional neuropeptide Y receptors are not coupled to a pertussis toxin-susceptible G protein.

References

Jan 1, 1977·Reviews of Physiology, Biochemistry and Pharmacology·K Starke
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D A EwaldR J Miller
Jan 1, 1988·Trends in Neurosciences·R J Miller
Mar 15, 1988·Biochemical and Biophysical Research Communications·E E Reynolds, S Yokota
Sep 1, 1988·Journal of Autonomic Pharmacology·J R Docherty
Sep 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·I MusgraveH Majewski
Jan 1, 1988·Pharmacology & Therapeutics·E K Potter
Jul 1, 1985·Acta Physiologica Scandinavica·B B FredholmL Edvinsson
Nov 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·C AllgaierG Hertting
May 1, 1988·Clinical and Experimental Pharmacology & Physiology·H K Wong-Dusting, M J Rand
May 1, 1987·The American Journal of Physiology·R J BarsottiD J Hartshorne
Apr 29, 1987·European Journal of Pharmacology·S PetrenkoG L Gessa
Aug 1, 1987·British Journal of Pharmacology·H JohnstonI F Musgrave
May 1, 1984·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J GuS R Bloom
Jan 1, 1986·Neurochemistry International·J M Allen, S R Bloom

❮ Previous
Next ❯

Citations

Feb 1, 1993·Journal of Neuroscience Research·G GimplH Kettenmann
Oct 1, 1991·Trends in Pharmacological Sciences·M C Michel
Jan 1, 1992·Progress in Neurobiology·Y DumontR Quirion
Dec 1, 1995·Australian and New Zealand Journal of Medicine·H K Majewski, I F Musgrave
Jan 1, 1990·Annals of the New York Academy of Sciences·H MajewskiI F Musgrave
May 31, 1993·Annals of the New York Academy of Sciences·S JegouH Vaudry
May 1, 1997·Journal of Cardiovascular Pharmacology·L C RumpP Schollmeyer
Feb 5, 2000·Neuropeptides·D R Gehlert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.